September 2026's European Penny Stocks To Watch

As of September 2026, European markets have experienced volatility, driven by escalating Middle East tensions and fluctuating energy prices, which have heightened inflation concerns and impacted bond yields. Despite these challenges, the concept of penny stocks remains relevant for investors seeking opportunities in smaller or newer companies that might offer growth potential. While the term may seem outdated, penny stocks can still represent affordable entry points into promising ventures when they boast strong financial health.

Here's a peek at a few of the choices from the screener.

Unify Group (ENXTPA:ALUNI)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Unify Group SA operates in the thematic media sector in France, with a market capitalization of €91.34 million.

Operations: The company's revenue is derived from two main segments: B to B, which generates €316 million, and B to C, contributing €213.3 million.

Market Cap: €91.34M

Unify Group SA, with a market cap of €91.34 million, operates in the thematic media sector in France. The company's financial health shows mixed signals for investors. While its EBIT covers interest payments 4.3 times over and its debt-to-equity ratio has improved from 113.6% to 70.7% over five years, short-term liabilities exceed assets by €126.5 million, indicating liquidity concerns. Despite trading at a value below estimates and having experienced board members with an average tenure of 6.9 years, earnings are forecasted to decline slightly over the next three years, reflecting potential challenges ahead for growth stability.

• Take a closer look at Unify Group's potential here in our financial health report.
• Explore Unify Group's analyst forecasts in our growth report.

Electricité et Eaux de Madagascar Société Anonyme (ENXTPA:EEM)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Electricité et Eaux de Madagascar Société Anonyme operates in the real estate sector with a market capitalization of €11.42 million.

Operations: Electricité et Eaux de Madagascar Société Anonyme has not reported any specific revenue segments.

Market Cap: €11.42M

Electricité et Eaux de Madagascar Société Anonyme, with a market cap of €11.42 million, operates in the real estate sector and is pre-revenue. Despite this, it has become profitable recently and boasts a high Return on Equity at 20.3%. The company's financial structure appears robust as its short-term assets (€9.8M) surpass both short-term (€2.4M) and long-term liabilities (€1.8M). Additionally, its debt-to-equity ratio has significantly decreased over five years to 5.6%, though negative operating cash flow indicates challenges in covering debt through cash generation alone. The stock exhibits high volatility compared to the broader French market.

• Dive into the specifics of Electricité et Eaux de Madagascar Société Anonyme here with our thorough balance sheet health report.
• Gain insights into Electricité et Eaux de Madagascar Société Anonyme's historical outcomes by reviewing our past performance report.

BIOTON (WSE:BIO)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: BIOTON S.A. is a biotechnology company that develops, manufactures, markets, and sells pharmaceutical ingredients and medicinal products in Poland and internationally, with a market cap of PLN310.40 million.

Operations: BIOTON's revenue is primarily derived from its BIOLEK segment, contributing PLN26.50 million.

Market Cap: PLN310.4M

BIOTON S.A., with a market cap of PLN310.40 million, faces challenges typical of penny stocks, including recent financial setbacks. The company's revenue for the second quarter was PLN71.06 million, down from the previous year, resulting in a net loss of PLN9.16 million compared to a profit previously. Despite reducing its debt-to-equity ratio over five years to 8.3%, BIOTON remains unprofitable with negative return on equity and limited cash runway under one year if current trends persist. However, its short-term assets exceed liabilities, providing some financial stability amidst ongoing volatility in earnings performance and management changes.

• Get an in-depth perspective on BIOTON's performance by reading our balance sheet health report here.
• Learn about BIOTON's historical performance here.

Where To Now?

• Click here to access our complete index of 308 European Penny Stocks.
• Seeking Other Investments? The end of cancer? These 35 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com